Authors/Disclosures
|
Robert Laforce, Jr., MD, PhD
(CHU De Quebec)
|
Dr. Laforce has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Jean-Pierre Bouchard, MD, FAAN
|
No disclosure on file |
|
Guy A. Rouleau, MD, PhD, FAAN
(Montreal Neurological Institute and Hospital)
|
Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |
|
|
No disclosure on file |
|
Remi W. Bouchard, MD
(Hospital Enfant-Jesus)
|
No disclosure on file |
|
Nicolas Dupre, MD, FAAN
(CHU de Quebec - U Laval)
|
Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation. |
|
Brian Edlow, MD
|
Dr. Edlow has received research support from NIH. |
|
Brian Edlow, MD
|
Dr. Edlow has received research support from NIH. |